Cart Icon0
Menu

Search from website

Human IgG1-kappa antibody to SARS CoV-2 S1 RBD (clone 30C5)

 

Figure 1. Coomassie-stained SDS-PAGE analysis of monoclonal antibody to SARS-CoV-2 Spike RBD, clone 30C5. 4-12% gradient gel is used for analysis. Lane 1. Monoclonal antibody to SARS-CoV-2 Spike RBD, clone 30C5(-DTT). Lane 2. Size marker. Lane 3. Monoclonal antibody to SARS-CoV-2 Spike RBD, clone 30C5 (+DTT). Lane 4. Size marker.

       

Figure 2. HPLC analytical SEC for final product.

       

Figure 3. HPLC analytical SEC after 3 freeze-thaw cycles.

 

Select volume:

Quantity:

Catalogue #

R1-161-100

Name

Human IgG1-kappa antibody to SARS CoV-2 S1 RBD (clone 30C5)

Target

SARS-CoV-2 virus

Target Description

SARS-CoV-2 virus (PBMCs isolated from patients recovered from SARS-CoV-2 infection, antibodies discovered by using HybriFree Technology).

Alternative Names

Spike glycoprotein, S glycoprotein

Uniprot ID

P0DTC2

Clonality

Human monoclonal

Clone

30C5

Class

hIgG1

Reactivity

SARS-CoV-2 Spike RBD

Application

ELISA

Protocol

Monoclonal antibody working amount has to be established practically for each particular antigen and assay format.

Purification

Protein A affinity chromatography followed by desalting

Concentration

1 mg/ml

Buffer

PBS pH 7.4

Shipping

Shipped on dry ice.

Storage

Store in -65...-85 °C. Avoid multiple freeze-thaw cycles.

This product is for research use only

TECHNICAL ASSISTANCE

Please refer any technical questions to

technical.support@icosagen.com

Our locations

United States Office

77 Geary St. 5th Floor
San Francisco, CA 94108

European Office

Eerika tee 1
Õssu, Kambja vald
Tartu maakond 61713
Estonia
+372 737 7070
Shopping Cart